We evaluated the relationship between serum bilirubin levels and ankle-brachial index (ABI) to determine whether gender affected the relationship between bilirubin levels and peripheral arterial disease (PAD) in patients with hypertension. A total of 543 patients were included in our studies (78 patients with PAD and 465 without PAD). Peripheral arterial disease was defined as ABI <0.90 for either and/or both sides. Serum bilirubin levels were measured with a vanadate oxidation method by using fasting venous blood samples. Serum total bilirubin (TBiL) and direct bilirubin (DBiL) levels were higher in males compared with females (both P < .05). Total bilirubin and DBiL were significantly lower in the PAD group. After adjustment for cardiovascular risk factors, PAD was independently negatively related to TBiL and DBiL, with odds ratios (OR) 0.914 (95% confidence interval [CI]: 0.845-0.990) and 0.748 (95% CI: 0.572-0.977). In addition, there was a relationship between PAD and bilirubin levels (TBiL—OR = 0.884, 95% CI: 0.792-0.985; DBiL—OR = 0.621; 95% CI: 0.424-0.909) only in males but not in females. Future studies should further evaluate whether interventions that increase serum bilirubin levels will have a particular role in PAD prevention in males.
VitekL. Bilirubin and atherosclerotic diseases. Physiol Res. 2017;66:S11–S20.
2.
BarananoDERaoMFerrisCDSnyderSH. Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci U S A. 2002;99:16093–98.
3.
TsimikasSMillerYI. Oxidative modification of lipoproteins: mechanisms, role in inflammation and potential clinical applications in cardiovascular disease. Curr Pharm Des. 2011;17:27–37.
4.
LiHHorkeSForstermannU. Vascular oxidative stress, nitric oxide and atherosclerosis. Atherosclerosis. 2014;237:208–19.
5.
StockerRAmesBN. Potential role of conjugated bilirubin and copper in the metabolism of lipid peroxides in bile. Proc Natl Acad Sci U S A. 1987;84:8130–34.
6.
Gerhard-HermanMDGornikHLBarrettC, et al.2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2017;69:1465–1508.
7.
PerkJDe BackerGGohlkeH, et al.European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur Heart J.2012;33:1635–1701.
8.
OzekiMMoritaHMiyamuraM, et al.High serum bilirubin is associated with lower prevalence of peripheral arterial disease among cardiac patients. Clin Chim Acta. 2018;476:60–66.
9.
WangLBautistaLE. Serum bilirubin and the risk of hypertension. Int J Epidemiol. 2015;44:142–52.
10.
NanoJMukaTCepedaM, et al.Association of circulating total bilirubin with the metabolic syndrome and type 2 diabetes: a systematic review and meta-analysis of observational evidence. Diabetes Metab. 2016;42:389–97.
11.
AnderssonCWeekePFosbolEL, et al.Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the sibutramine cardiovascular outcome trial. Metabolism. 2009;58:1109–15.
12.
TsaiMTTarngDC. Beyond a measure of liver function-bilirubin acts as a potential cardiovascular protector in chronic kidney disease patients. Int J Mol Sci. 2018;20:117.
13.
LapennaDCiofaniGPierdomenicoSDGiamberardinoMAUcchinoSDaviG. Association of serum bilirubin with oxidant damage of human atherosclerotic plaques and the severity of atherosclerosis. Clin Exp Med. 2018;18:119–24.
14.
HuangYHYangYCLuFHSunZJWuJSChangCJ. Serum bilirubin is inversely associated with increased arterial stiffness in men with pre-hypertension but not normotension. PLoS One. 2016;11:e0146226.
15.
LiaoKP. Cardiovascular disease in patients with rheumatoid arthritis. Trends Cardiovasc Med. 2017;27:136–40.
16.
LinJPO’DonnellCJSchwaigerJP, et al.Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham heart study. Circulation. 2006;114:1476–81.
17.
BreimerLHWannametheeGEbrahimSShaperAG. Serum bilirubin and risk of ischemic heart disease in middle-aged British men. Clin Chem. 1995;41:1504–8.
18.
LiuHLiuJZhaoH, et al.The design and rationale of the Beijing Vascular Disease Patients Evaluation Study (BEST study). Contemp Clin Trials Commun. 2017;7:18–22.
19.
ZuoLMaYCZhouYHWangMXuGBWangHY. Application of GFR-estimating equations in Chinese patients with chronic kidney disease. Am J Kidney Dis. 2005;45:463–72.
20.
AboyansVCriquiMHAbrahamP, et al.Measurement and interpretation of the ankle-brachial index: a scientific statement from the American heart association. Circulation. 2012;126:2890–909.
21.
SchroderFDiehmNKareemS, et al.A modified calculation of ankle-brachial pressure index is far more sensitive in the detection of peripheral arterial disease. J Vasc Surg. 2006;44:531–6.
22.
GuoXLiJPangW, et al.Sensitivity and specificity of ankle-brachial index for detecting angiographic stenosis of peripheral arteries. Circ J. 2008;72:605–10.
23.
VitekLNovotnyLSperlMHolajRSpacilJ. The inverse association of elevated serum bilirubin levels with subclinical carotid atherosclerosis. Cerebrovasc Dis. 2006;21:408–14.
24.
HamurHDumanHDemirtasL, et al.Total bilirubin levels predict subclinical atherosclerosis in patients with prediabetes. Angiology. 2016;67:909–15.
25.
ErdoganDGulluHYildirimE, et al.Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women. Atherosclerosis. 2006;184:431–7.
26.
ZhangZYBianLQKimSJZhouCCChoiYH. Inverse relation of total serum bilirubin to coronary artery calcification score detected by multidetector computed tomography in males. Clin Cardiol. 2012;35:301–6.
27.
KimNHKimHCLeeJYLeeJMSuhI. Active and passive smoking and serum total bilirubin in a rural Korean population. Nicotine Tob Res. 2016;18:572–9.
28.
OdaE. A decrease in total bilirubin predicted hyper-LDL Cholesterolemia in a health screening population. Atherosclerosis. 2014;235:334–8.
29.
NishimuraTTanakaM. Serum total bilirubin concentration in patients with type 2 diabetes as a possible biomarker of polyvascular disease. Diabetol Int. 2018;9:129–35.
30.
OngKLWuBJCheungBMBarterPJRyeKA. Association of lower total bilirubin level with statin usage: the United States national health and nutrition examination survey 1999-2008. Atherosclerosis. 2011;219:728–33.
31.
EndlerGHamwiASunder-PlassmannR, et al.Is low serum bilirubin an independent risk factor for coronary artery disease in men but not in women?Clin Chem. 2003;49:1201–4.
32.
PerlsteinTSPandeRLBeckmanJACreagerMA. Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: national health and nutrition examination survey (NHANES) 1999 to 2004. Arterioscler Thromb Vasc Biol. 2008;28:166–72.
33.
WaldenCEKnoppRHJohnsonJLHeissGWahlPWHooverJJ. Effect of estrogen/progestin potency on clinical chemistry measures. The lipid research clinics program prevalence study. Am J Epidemiol. 1986;123:517–31.
34.
WhitfieldJBZhuGNestlerJEHeathACMartinNG. Genetic covariation between serum gamma-glutamyltransferase activity and cardiovascular risk factors. Clin Chem. 2002;48:1426–31.
AkbogaMKCanpolatUSahinarslanA, et al.Association of serum total bilirubin level with severity of coronary atherosclerosis is linked to systemic inflammation. Atherosclerosis. 2015;240:110–4.
37.
BreimerLHSpyropolousKAWinderAFMikhailidisDPHamiltonG. Is bilirubin protective against coronary artery disease?Clin Chem. 1994;40:1987–8.
38.
SongYSKooBKChoNHMoonMK. Effect of low serum total bilirubin levels (≤0.32 mg/dl) on risk of coronary artery disease in patients with metabolic syndrome. Am J Cardiol. 2014;114:1695–1700.
39.
VogelMEIdelmanGKonaniahESZuckerSD. Bilirubin prevents atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice by inhibiting endothelial VCAM-1 and ICAM-1 signaling. J Am Heart Assoc. 2017;6:e004820.
40.
StockerRPerrellaMA. Heme oxygenase-1: a novel drug target for atherosclerotic diseases?Circulation. 2006;114:2178–89.
41.
FredenburghLEMerzAAChengS. Haeme oxygenase signalling pathway: implications for cardiovascular disease. Eur Heart J. 2015;36:1512–8.
42.
LinRWangYWangY, et al.Common variants of four bilirubin metabolism genes and their association with serum bilirubin and coronary artery disease in Chinese Han population. Pharmacogenet Genomics. 2009;19:310–8.
43.
LiRYCaoZGZhangJRLiYWangRT. Decreased serum bilirubin is associated with silent cerebral infarction. Arterioscler Thromb Vasc Biol. 2014;34:946–51.
44.
NajamSSSunJZhangJ, et al.Serum total bilirubin levels and prevalence of diabetic retinopathy in a Chinese population. J Diabetes. 2014;6:221–7.
45.
LinLYKuoHKHwangJJ, et al.Serum bilirubin is inversely associated with insulin resistance and metabolic syndrome among children and adolescents. Atherosclerosis. 2009;203:563–8.
46.
ZhangMMGaoYZhengYY, et al.Association of fasting serum bilirubin levels with clinical outcomes after percutaneous coronary intervention: a prospective study. Cardiovasc Toxicol. 2017;17:471–7.
47.
FrikhaZFerreiraJPBozecE, et al.Relation of high serum bilirubin to short-term mortality following a myocardial infarction complicated by left ventricular systolic dysfunction (from the high-risk myocardial infarction database initiative). Am J Cardiol. 2018;121:1015–20.
48.
ChungSRYangTHShinHC, et al.Initial total bilirubin and clinical outcome in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with drug-eluting stents. Circ J. 2016;80:1437–44.
49.
CelikTKayaMGAkpekM, et al.Does serum bilirubin level on admission predict TIMI flow grade and in-hospital MACE in patients with STEMI undergoing primary PCI. Angiology. 2014;65:198–204.
